News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Mulls Sale Of Older Drugs, Plans To Put Dengue Vaccine Program In Separate Unit


6/26/2014 4:14:17 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS, June 25 (Reuters) - French drugmaker Sanofi is in the "very early stages" of considering the sale of a portfolio of older drugs, managers told an internal meeting on Wednesday, according to union representatives who were present.

People familiar with the matter had told Reuters in April that Sanofi was looking to part with drugs that could fetch $7-8 billion as it seeks to shed non-core assets and focus on high-growth areas.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES